RS BioTherapeutics, Inc.
Deadline passed 2024-07-29Corporation · Delaware · Incorporated 2021-02-08
- CIK 1932193
- File 020-34040
- State DE
- Target Amount
- $10,000
- minimum to close
- Maximum Amount
- $1,235,000
- ceiling, with over-subscription
- Deadline
- 2024-07-29
- as the latest Form C set it
Connected
named in its Form C filingsThe intermediary named in this company’s Form C filings. Investments in a Regulation Crowdfunding offering can only be made through them.
Latest Reported Offering
The terms on the latest Form C
Security Details
- Type
- Other
- Price per share
- $0.00
- Price set by
- N/A
- Shares offered
- 10,000+
Offering Costs
- Cash commission
- —
- 7 - 13 percent
- Equity compensation
- —
- Three percent (3%) of securities of the total amount of investments raised in the offering, along the same terms as investors.
Campaign timeline
target amount · by first filed- 2024-04-29$10,000020-34040
Hover a dot or row, or tab through the dots · bars scaled to the largest round ($10,000)
Reg D offerings
4 offeringsPrivate placements reported on Form D, separate from the crowdfunding raise: Reg CF sales are never counted in their sold amounts
| File | First filed | Latest | Sought | Sold | Investors | Exemption |
|---|---|---|---|---|---|---|
| 021-526303 | First filed2024-10-09 | Latest2024-10-09 | Sought$2M | Sold$20K | Investors1 | Exemption506(b) |
| 021-489382 | First filed2023-08-10 | Latest2023-10-19 | Sought$5M | Sold$1.1M | Investors5 | Exemption506(b) |
| 021-476630 | First filed2023-03-22 | Latest2023-03-22 | Sought$10M | Sold$100K | Investors1 | Exemption506(b) |
| 021-449739 | First filed2022-06-21 | Latest2022-06-21 | Sought$4M | Sold$685K | Investors6 | Exemption506(b) |
Filing history
Form C family — 6 filingsCompany Information
- Legal Status
- Corporation
- Jurisdiction
- Delaware
- Date of Incorporation
- 2021-02-08
- Website
- http://rsbiotherapeutics.com
Latest Metrics
Most recent fiscal year, as the latest filing reports it
- Employees
- 2
- Total Assets
- $13,808
- Cash on Hand
- $9,303
- Revenues
- $1,779
- Net Income
- -$204,031
The reported figures behind RS BioTherapeutics, Inc.
Form C prints a most-recent and a prior fiscal year side by side but never names them. The dashboard chains every filing into those years and plots them. EDGAR still has each Form C-AR; the dashboard lays every year they filed next to it.
- Reported financials chained into fiscal years — revenue, income, assets, cash — not one filing at a time
- A sparkline on each figure so the shape is visible before the numbers
- A revenue series dated to the filings that reported it
- The campaign as filed: target, ceiling, deadline, and the portal that ran it
- Follow it, and see it change on your watchlist
Part of the Crowdfunding plan — $40/mo at launch pricing ($100 list)
See plans
